Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma

Published:2015-06-25 Issue:8 Volume:106 Page:1016-1022
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Nakao Keisuke¹²,Tanaka Shinji¹²,Miura Tomoya²,Sato Kota²,Matsumura Satoshi²,Aihara Arihiro²,Mitsunori Yusuke²,Ban Daisuke²,Ochiai Takanori²,Kudo Atsushi²,Arii Shigeki²,Tanabe Minoru²

Affiliation:

1. Department of Molecular Oncology Graduate School of Medicine Tokyo Medical and Dental University Tokyo Japan

2. Department of Hepato‐Biliary‐Pancreatic Surgery Graduate School of Medicine Tokyo Medical and Dental University Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12701

Reference25 articles.

1. SnapShot: Hepatocellular Carcinoma

2. Management of hepatocellular carcinoma: An update

3. Sorafenib in Advanced Hepatocellular Carcinoma

4. HCC therapies—lessons learned

5. Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression;BMC Cancer;2023-07-03

2. Dandelion Polysaccharide Exerts Anti-Angiogenesis Effect on Hepatocellular Carcinoma by Regulating VEGF/HIF-1α Expression;Frontiers in Pharmacology;2020-04-08

3. CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo;Experimental Cell Research;2018-08

4. Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma;Molecular Cancer Therapeutics;2017-02-28

5. Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases;Journal of Experimental & Clinical Cancer Research;2016-11-25